OBJECTIVE -Few studies have assessed whether 24-h blood pressure control induced by antihypertensive agents improves macroalbuminuria in hypertensive type 2 diabetic patients with overt nephropathy. We evaluated the effects of losartan and amlodipine on 24-h blood pressure, autonomic nervous activity, and albuminuria in these patients.
RESEARCH DESIGN AND METHODS-In this open-label, parallel-prospective, randomized study, 44 patients were treated with losartan and 43 with amlodipine for a 12-week titration phase and a maintenance phase for a maximum of 12 weeks. Twenty-four-hour blood pressure and urinary albumin excretion were measured before and during treatment. Simultaneously, power spectral analysis of heart rate was performed to evaluate low frequency (LF) and high frequency (HF) components and LF-to-HF ratios as an index of sympathovagal balance.RESULTS -Losartan decreased (P Ͻ 0.001) mean blood pressure from 162/91 to 150/82 mmHg during daytime and from 146/82 to 137/74 mmHg during nighttime (systolic/diastolic). Amlodipine also decreased (P Ͻ 0.001) blood pressure from 159/90 to 147/82 mmHg during daytime and from 143/81 to 131/72 mmHg during nighttime. LF and HF components and nighttime-to-daytime ratios for the LF-to-HF ratios did not differ during treatment in two groups, showing no changes in the diurnal autonomic nervous rhythm. Losartan decreased (P Ͻ 0.001) 24-h urinary albumin excretion from 810 mg/day (95% CI 780 -1,140) to 570 (510 -910). Amlodipine, however, did not decrease (P ϭ 0. CONCLUSIONS -These results suggest that in type 2 diabetes with overt nephropathy, 24-h blood pressure regulation alone is inadequate to reduce macroalbuminuria and additional effects of losartan are crucial for antiproteinuric action.
Diabetes Care 28:1862-1868, 2005T he circadian pattern of blood pressure in patients with diabetic nephropathy shows a loss of nocturnal blood pressure reduction (1,2). Impaired diurnal autonomic nervous rhythm is one of the causes that blunt nocturnal decline in blood pressure (2) and increase urinary albumin excretion (3). Thus, there is a close relation between loss of nocturnal blood pressure fall and albuminuria in diabetic nephropathy (4), although it remains controversial as to which precedes. If loss of nocturnal blood pressure decline hastens the development of albuminuria, intensified nocturnal blood pressure regulation by antihypertensive treatment can be expected to decrease the risk of albuminuria. In fact, several classes of antihypertensive agents have been reported to reduce blood pressure throughout 24 h in hypertensive patients with diabetes (5-7). However, in hypertensive patients with advanced type 2 diabetic nephropathy, it is important to clarify whether 24-h blood pressure control, especially nocturnal blood pressure reduction, induced by antihypertensive agents improves macroalbuminuria, a well-established predictor of end-stage renal disease.The aim of the present prospective study was to compare the effects of losartan, an angiotensin II receptor blocker, w...